The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

BACKGROUND: Our objective was to investigate the efficacy of the beta-3 adrenergic receptor (β3-AR) agonist BRL37344 for the prevention of liver steatosis and inflammation associated with nonalcoholic fatty liver disease (NAFLD). METHODS: Four groups were established: a control group (given a standa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziwen, Li, Shanshan, Wang, Ruifeng, Guo, Liansheng, Xu, Dan, Zhang, Tieyuan, Xu, Yifan, Wang, Wenlong, Wang, Min, Gan, Zhongwei, Wang, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275314/
https://www.ncbi.nlm.nih.gov/pubmed/32503411
http://dx.doi.org/10.1186/s10020-020-00164-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275314/
https://www.ncbi.nlm.nih.gov/pubmed/32503411
http://dx.doi.org/10.1186/s10020-020-00164-4

Ejemplares similares